Epilepsy Wire
Comprehensive News Feed for Epilepsy.
Results 1 - 20 of 452 in Epilepsy
-
Proper diagnosis key to treating epilepsy: expert
VISAKHAPATNAM: A seminar organised by Indian Academy of Paediatrics and Indian Epilepsy Association here on Sunday focussed on management of epilepsy and seizures in children. Comment?
-
Proper diagnosis and controlling it with a single drug is crucial in treating epilepsy, says Professor of Neurology K. Venkateswarlu. Comment?
-
... new drugs. Nonetheless, revenue has fallen because of generic competition for its antipsychotic drug Risperdal and epilepsy treatment Topamax, while the Food and Drug Administration this year required stronger warnings on several J&J drugs. The ... Comment?
-
... be Anencephaly (the baby has no skull, and just a brain stem) or Spinal Bifida." - Jacie's online journal Jacie has epilepsy; she had her first seizure when she was about 13. Tegretol, the medication she took to control her seizures, is a risk ... Comment?
-
Aiden Edward Harley lived only 51 minutes, but for family and friends his time was
... be Anencephaly (the baby has no skull, and just a brain stem) or Spinal Bifida." - Jacie's online journal Jacie has epilepsy; she had her first seizure when she was about 13. Tegretol, the medication she took to control her seizures, is a risk ... Comment?
-
Epilepsy is a neurological condition that affects more than 2 million people in the United States. Comment?
-
Travolta "heartbroken" over son's death
... Ossi and Michael McDermott, were quoted on Sunday as saying Jett apparently suffered from grand mal, a type of epilepsy marked by convulsions and loss of consciousness. He was on an anti-seizure medication called Depakote for several years, Ossi and ... Comment?
-
Health Tip: What's Prompting My Seizures?
A seizure is a sudden spurt of abnormal electrical activity in the brain. While the causes can be varied and complex, the Epilepsy Foundation offers this list of common triggers: Missing medications, especially those used to control seizures. Comment?
-
Hot Drug Stock in Need of a Chill
... portfolio of specialty drugs. This year, some investors have gotten rather excited over a prospective drug for epilepsy -- which Valeant ( VRX ) and partner GlaxoSmithKline ( GSK ) just submitted for regulatory approval, sending Valeant shares ... Comment?
-
Operation Bootstrap gets $10,000 lift
... it keeps all the money local. They have donated to national charities in the past, such as the diabetes fund and epilepsy foundation. At their annual parties they match whatever donations their clients pledge to a certain charity. Roseann DeBot, ... Comment?
-
... of a Chill Pill," November 23, 2009) warned that investors may be overestimating the potential for an experimental epilepsy drug to offset waning revenue. Shares ... Comment?
-
Epilepsy is a neurological condition that affects more than 2 million people in the United States. Comment?
-
Valeant Pharma (VRX) falls on bearish Barron's coverage
Filed under: Major movement , Bad news , Newspapers , Magazines , Options , Technical Analysis Valeant Pharmaceuticals stock is trading lower today after an article in Barron's over the weekend said the company could see trouble ahead if its experimental epilepsy drug, which is undergoing the regulatory review process, is not profitable enough to ... Comment?
-
The Use of CAM Therapies and Treatments for Epilepsy
Epilepsy is a much more common condition than you might think. There are several different forms of epilepsy. Comment?
-
Valeant Pharmaceuticals International May Fall if New Drug Disappoints-Barron's
Investors could shave off a third of the valuation of Valeant Pharmaceuticals International if its prospective epilepsy drug retigabine fails to live up to expectations, according to a Barron's report. Comment?
-
Barron's Says Valeant Could Plunge if Epilepsy Drug Comes Up Short
Posted 07:18 PM ET Nov 22, 2009 News Watch via COMTEX) -- 11/23/2009-In Barron's most recent publication the paper said shares of Valeant Pharmaceuticals International could lose a third of their valuation if its possible epilepsy drug retigabine fails to meet expectations. Comment?
-
This Weekend's Barron's: Dividend Paying Stocks; BB&T Is the Banking...
... produced a better outcome. Hot Drug Stock in Need of a Chill Pill . Valeant Pharmaceuticals has a promising new epilepsy treatment, but too much has to go just right to justify the shares' recent price. Barron's examines the outlook for the ... Comment?
-
Expressions of Courage- Artwork by people with Epilepsy
... The contest has grown annually and the artwork is a true reflection of how these special people cope with their Epilepsy. Epilepsy is one of the most common disorders of the nervous system, affecting approximately 50 million people worldwide with as ... Comment?
-
New Certified Reference Materials Offer Greater Certainty In Monitoring 3 Therapeutic Medications
... new CRMs are for carbamazepine, an anticonvulsant and mood stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder; phenytoin, commonly used as an antiepileptic; and theophylline, used in the treatment of respiratory ... Comment?
-
The New Berlin Eisenhower and West girls basketball teams are once again teaming up to "Shoot for a Cure" to help fight epilepsy this season. Comment?
Epilepsy Forum
Most Popular
- Republican blasts ACORN reprieve - 229 comments
- Ten percent of South African women report anal sex in the past three months - 250 comments
- Concealed carry does not make us safer - 128 comments
- Why Not A Black Santa? - 73 comments
- Tiger Woods Car Crash Update: After fight with wife he hit fire hydrant then ... - 50 comments
- "Indecent" Skirt Earns Sudanese Girl 50 Lashes - 77 comments
- Senate report: Bin Laden was 'within our grasp' - 64 comments
- Switzerland to vote on minarets - 142 comments
- Senate report: Bin Laden was 'within our grasp' - 108 comments
- Britain, France back global fund to help poor countries reach goals for easin... - 48 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
